#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#
CS
proLékaře.cz

Diabetes and obesity - Issue 45/2023

Editorial

3
Quo vadis, slovenská diabetológia?

Reviews

9
The dual GIP and GLP1 receptor agonist tirzepatide: a new effective treatment for type 2 diabetes mellitus

Vladimír Uličiansky

18
Diabetes mellitus and options for early prevention of heart failure

Andrej Dukát, Peter Jackuliak, Juraj Payer

22
Evaluation of the current situation and possibilities in the management of obesity in Slovakia

Ubomíra Fábryová

29
Ceramides and cardiovascular disease

Ján Murín

34
Social services in diabetes mellitus

Andrea Bukovská

Case studies

37
Practical experience with dapagliflozin: case reports

Viliam Vaník, Zbynek Schroner

43
The patient with type 2 diabetes is hemodynamically and metabolically stable, despite treatment, the progression of chronic kidney disease proceeds. What other options do we have? A case report

Zbynek Schroner

Clinical studies

49
Empagliflozin in patients with chronic kidney disease: results of the EMPA-KIDNEY trial and implications for clinical practice

Peter Novodvorský

54
The head-to-head comparison of insulin glargine 300 units/ml and degludec 100 units/ml using the CGM technology: results of the InRange trial

Peter Novodvorský

News

61
New indication criteria: better availability of GLP1 receptor agonists for our patients

Zbynek Schroner

63
The SGLT2 inhibitor canagliflozin: benefits in the treatment of type 2 diabetes mellitus

Zbynek Schroner

Personal news

66
Spomienka na MUDr. Blaženu Dyskovú

News

67
A glimpse into the 13th chamber – overt and covert manifestations of diabetes mellitus

Jozef Lacka

71
World Diabetes Congress, Lisabon 2022

Andrea Bukovská

73
Advanced Technologies & Treatments for Diabetes 2023, Berlín

Martin Haluzík

77
5th National SDS Symposium: How are we doing with technology in diabetology in Slovakia and what new things do we expect in the future?

Viera Doničová

Diabetes and obesity

Issue 45
2023 Issue 45
Most read in this issue
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#